Skip to main content
. Author manuscript; available in PMC: 2022 Jun 2.
Published in final edited form as: Cell Rep. 2022 May 10;39(6):110783. doi: 10.1016/j.celrep.2022.110783

Figure 1. Experimental design.

Figure 1.

(A) Depiction of how C57BL/6NHsd mice were randomly assigned to groups receiving nothing (control), enrofloxacin, or VAMN in the drinking water, and housing 4 or 2 mice per cage (n = 12 mice/group).

(B) Depiction of treatment and study duration in cohort 1 (N = 48), including control and enrofloxacin-treated groups, and cohort 2 (N = 72), including controls, enrofloxacin-treated, and VAMN-treated groups, and the timing and nature of each sample collection.